Shire subsidiaries settled litigation with Actavis and Watson Laboratories

Pharmaceuticals group Shire has said its subsidiary Shire LLC, has settled all pending litigation with Actavis and Watson Laboratories.

Pharmaceuticals group Shire has said its subsidiary Shire LLC, has settled all pending litigation with Actavis and Watson Laboratories.

The litigation was in relation Actavis and Watson's abbreviated new drug applications (ANDAs) for generic versions of Shire's Intuniv product for the treatment of Attention Deficit Hyperactivity Disorder (ADHD).

The settlement provides Actavis with a licence to make and market its generic versions of Intuniv in the US on December 1st 2014, and any sales will results in royalty payments of 25% of gross profits to Shire during the 180 day exclusivity period.

The settlement also provides Watson with a licence to make and market Watson's generic versions of Intuniv in the US 181 days after Actacis's own launch.

NR

Recommended

Share tips of the week – 24 September
Share tips

Share tips of the week – 24 September

MoneyWeek’s comprehensive guide to the best of this week’s share tips from the rest of the UK's financial pages.
24 Sep 2021
Three strong Asian stocks trading at bargain prices
Share tips

Three strong Asian stocks trading at bargain prices

Professional investor Nitin Bajaj of the Fidelity Asian Values investment trust picks three stocks that dominate their industries, earn good returns o…
20 Sep 2021
Why it pays to face up to your investment mistakes
Investment strategy

Why it pays to face up to your investment mistakes

Buying stocks can be a complicated business. But selling stocks can be tricky, too – even if you sell for the right reasons. Max King explains how to …
17 Sep 2021
Share tips of the week – 17 September
Share tips

Share tips of the week – 17 September

MoneyWeek’s comprehensive guide to the best of this week’s share tips from the rest of the UK's financial pages.
17 Sep 2021

Most Popular

A nightmare 1970s scenario for investors is edging closer
Investment strategy

A nightmare 1970s scenario for investors is edging closer

Inflation need not be a worry unless it is driven by labour market shortages. Unfortunately, writes macroeconomist Philip Pilkington, that’s exactly w…
17 Sep 2021
Two shipping funds to buy for steady income
Investment trusts

Two shipping funds to buy for steady income

Returns from owning ships are volatile, but these two investment trusts are trying to make the sector less risky.
7 Sep 2021
Should investors be worried about stagflation?
US Economy

Should investors be worried about stagflation?

The latest US employment data has raised the ugly spectre of “stagflation” – weak growth and high inflation. John Stepek looks at what’s going on and …
6 Sep 2021